Financials Medical Ikkou Group Co.,Ltd.

Equities

3353

JP3921040006

Drug Retailers

Market Closed - Japan Exchange 01:20:40 2024-06-14 am EDT 5-day change 1st Jan Change
2,600 JPY -1.85% Intraday chart for Medical Ikkou Group Co.,Ltd. 0.00% +26.03%

Valuation

Fiscal Period: February 2019 2020 2021 2022 2023 2024
Capitalization 1 17,270 16,488 11,307 9,578 9,727 8,775
Enterprise Value (EV) 1 23,068 20,970 16,151 12,897 12,399 10,652
P/E ratio 24.4 x 20.6 x 13.6 x 11.2 x 12.8 x 8.44 x
Yield 0.88% 0.92% 2.66% 1.57% 1.54% 1.93%
Capitalization / Revenue 0.55 x 0.51 x 0.36 x 0.29 x 0.29 x 0.22 x
EV / Revenue 0.74 x 0.65 x 0.51 x 0.38 x 0.37 x 0.27 x
EV / EBITDA 12.2 x 10.3 x 8.66 x 6.01 x 6.98 x 4.55 x
EV / FCF -34.8 x 14.9 x 15.6 x 13.8 x 16.7 x 8.23 x
FCF Yield -2.87% 6.72% 6.43% 7.27% 5.99% 12.2%
Price to Book 1.81 x 1.62 x 1.08 x 0.84 x 0.81 x 0.66 x
Nbr of stocks (in thousands) 3,812 3,812 3,757 3,756 3,757 3,758
Reference price 2 4,530 4,325 3,010 2,550 2,589 2,335
Announcement Date 5/23/19 5/28/20 5/27/21 5/26/22 5/25/23 5/23/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: February 2019 2020 2021 2022 2023 2024
Net sales 1 31,222 32,042 31,603 33,595 33,897 39,900
EBITDA 1 1,892 2,030 1,865 2,145 1,776 2,342
EBIT 1 1,044 1,205 1,030 1,275 935 1,559
Operating Margin 3.34% 3.76% 3.26% 3.8% 2.76% 3.91%
Earnings before Tax (EBT) 1 1,167 1,271 1,443 1,476 1,312 1,661
Net income 1 711 801 836 852 759 1,039
Net margin 2.28% 2.5% 2.65% 2.54% 2.24% 2.6%
EPS 2 185.8 210.1 221.6 226.8 202.0 276.5
Free Cash Flow 1 -662.6 1,409 1,039 937.6 743.1 1,295
FCF margin -2.12% 4.4% 3.29% 2.79% 2.19% 3.24%
FCF Conversion (EBITDA) - 69.4% 55.69% 43.71% 41.84% 55.28%
FCF Conversion (Net income) - 175.89% 124.24% 110.05% 97.91% 124.6%
Dividend per Share 2 40.00 40.00 80.00 40.00 40.00 45.00
Announcement Date 5/23/19 5/28/20 5/27/21 5/26/22 5/25/23 5/23/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: February 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 15,522 16,812 8,399 8,563 16,978 8,449 8,721 17,450 11,319
EBITDA - - - - - - - - -
EBIT 1 395 648 360 239 465 240 294 603 475
Operating Margin 2.54% 3.85% 4.29% 2.79% 2.74% 2.84% 3.37% 3.46% 4.2%
Earnings before Tax (EBT) 1 708 784 396 333 624 373 374 775 499
Net income 1 434 445 225 208 374 223 211 444 368
Net margin 2.8% 2.65% 2.68% 2.43% 2.2% 2.64% 2.42% 2.54% 3.25%
EPS 2 114.8 118.6 59.73 55.39 99.65 59.35 56.42 118.3 97.94
Dividend per Share 20.00 20.00 - - 20.00 - - 20.00 -
Announcement Date 9/30/20 9/30/21 1/11/22 7/4/22 10/3/22 1/10/23 7/3/23 10/2/23 1/10/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: February 2019 2020 2021 2022 2023 2024
Net Debt 1 5,798 4,482 4,844 3,319 2,672 1,877
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 3.064 x 2.208 x 2.597 x 1.547 x 1.505 x 0.8015 x
Free Cash Flow 1 -663 1,409 1,039 938 743 1,295
ROE (net income / shareholders' equity) 7.54% 8.12% 8.09% 7.75% 6.29% 8.17%
ROA (Net income/ Total Assets) 2.51% 2.87% 2.35% 2.76% 2.06% 3.29%
Assets 1 28,297 27,870 35,550 30,819 36,757 31,544
Book Value Per Share 2 2,505 2,668 2,791 3,031 3,207 3,523
Cash Flow per Share 2 1,392 1,494 1,864 2,128 1,715 2,049
Capex 1 1,084 451 470 322 311 302
Capex / Sales 3.47% 1.41% 1.49% 0.96% 0.92% 0.76%
Announcement Date 5/23/19 5/28/20 5/27/21 5/26/22 5/25/23 5/23/24
1JPY in Million2JPY
Estimates
  1. Stock Market
  2. Equities
  3. 3353 Stock
  4. Financials Medical Ikkou Group Co.,Ltd.